WHO Warns Cancer Cases Could Nearly Double by 2050, Urges Stronger Prevention and Early Detection

Cancer continues to be one of the world’s biggest health challenges, and a new global assessment from the World Health Organization has warned that the number of new cancer cases could rise dramatically over the coming decades if countries do not accelerate prevention, early detection and access to treatment.

The WHO Global Status Report on Cancer 2026, released in July, estimates that there are currently around 20.6 million new cancer cases and nearly 10 million cancer deaths each year. Without stronger action, annual new cases could approach 35 million by 2050.

The warning comes alongside evidence that a substantial share of cancer cases can be prevented through changes in public-health policies and individual risk factors.

Cancer Remains a Major Global Health Burden

Cancer is currently the second leading cause of death globally, according to WHO.

The disease includes a large group of conditions in which abnormal cells grow uncontrollably and can spread to other parts of the body.

The most common cancers include lung, breast, colorectal and prostate cancers.

WHO’s latest fact sheet estimates that cancer caused nearly 10 million deaths in 2024, representing approximately one in every six deaths worldwide.

The growing burden is being driven by several factors, including population ageing, population growth and changes in exposure to risk factors.

Why Cases Could Rise Sharply

The projected increase does not mean that cancer will inevitably become more common at the same rate everywhere.

Population growth and ageing are major contributors because cancer risk generally increases with age.

At the same time, lifestyle and environmental factors are influencing cancer patterns.

WHO has highlighted tobacco use, unhealthy diets, physical inactivity, excess body weight, alcohol consumption and air pollution among important contributors to cancer risk.

Without stronger prevention policies, these factors could contribute to a substantial increase in future cases.

A Large Share of Cancer Is Preventable

One of the most encouraging findings from recent WHO and IARC research is that a significant proportion of cancer cases are linked to preventable causes.

A global analysis published in 2026 estimated that 37% of new cancer cases in 2022—about 7.1 million cases—were associated with preventable causes.

The analysis examined 30 preventable causes, including tobacco, alcohol, high body mass index, physical inactivity, air pollution, ultraviolet radiation and cancer-causing infections.

This means prevention could potentially have a major impact on the future global cancer burden.

Tobacco Remains the Biggest Preventable Risk

Smoking continues to be the leading preventable cause of cancer worldwide.

WHO and IARC estimate that tobacco was responsible for around 15% of all new cancer cases globally in the 2022 analysis.

Smoking is strongly associated with lung cancer and also contributes to several other cancer types.

Reducing tobacco consumption through taxation, advertising restrictions, smoke-free policies, cessation services and public education remains one of the most effective cancer-prevention strategies.

Infections Also Play a Major Role

Cancer is not always caused by lifestyle factors.

Certain infections can increase cancer risk.

Human papillomavirus, or HPV, is strongly associated with cervical cancer, while hepatitis viruses can contribute to liver cancer.

WHO’s global analysis estimated that cancer-causing infections accounted for approximately 10% of new cancer cases globally in 2022.

Vaccination and infection prevention can therefore form an important part of cancer-control programmes.

Cervical Cancer Offers a Major Prevention Opportunity

Cervical cancer is one of the clearest examples of a cancer that can be prevented and detected early.

Almost all cervical cancer cases are linked to persistent infection with high-risk HPV.

WHO recommends combining HPV vaccination with effective cervical cancer screening and treatment of precancerous lesions.

In May 2026, WHO issued updated guidance on using HPV DNA genotyping to improve cervical pre-cancer screening and help identify women who need closer follow-up.

Breast Cancer Remains a Major Concern

Breast cancer is another major part of the global cancer burden.

WHO estimates that breast cancer caused approximately 694,000 deaths worldwide in 2024 and was the most common cancer among women in 164 of 186 countries that year.

Early diagnosis is particularly important because treatment is generally more effective when cancer is identified before it has spread.

WHO’s Global Breast Cancer Initiative focuses on health promotion, timely diagnosis and comprehensive cancer management.

Early Detection Can Save Lives

Prevention is only one part of the solution.

Some cancers cannot be completely prevented, making early detection critical.

Screening programmes are designed to identify cancer or pre-cancerous changes before symptoms develop.

However, screening is not appropriate in the same way for every cancer or every population.

WHO notes that screening strategies should be based on evidence, age, risk factors and the capacity of health systems to provide follow-up diagnosis and treatment.

Treatment Access Remains Unequal

Scientific progress has produced new medicines, technologies and treatment approaches.

However, access to those advances remains highly unequal.

People living in countries or communities with limited healthcare resources may face delays in diagnosis, shortages of specialists and restricted access to essential medicines.

WHO’s 2026 cancer report highlights persistent inequalities between countries and within populations.

This means reducing cancer deaths will require not only scientific innovation but also stronger health systems.

The Economic Cost of Cancer

Cancer creates significant economic pressure on families and health systems.

Treatment can involve surgery, radiation, chemotherapy, targeted medicines, immunotherapy and long-term follow-up.

Patients may also lose income because of illness or the need to care for family members.

Preventing cancer and detecting it earlier can therefore produce benefits that extend beyond health outcomes.

Lifestyle and Environment Matter

Individuals can reduce some cancer risks through healthier behaviours.

Avoiding tobacco, limiting alcohol consumption, maintaining a healthy body weight, staying physically active and following a balanced diet can reduce exposure to several established risk factors.

However, individual choices alone cannot solve the global cancer problem.

Air pollution, workplace exposures, access to healthy food and opportunities for physical activity are also influenced by government policies and the environments in which people live.

Air Pollution Is an Increasing Concern

Air pollution has become an important area of cancer research and prevention.

Long-term exposure to certain pollutants is associated particularly with lung cancer.

Reducing air pollution therefore has potential benefits extending beyond respiratory and cardiovascular health.

WHO has identified cleaner air as one of the areas where coordinated public policy can contribute to cancer prevention.

The Importance of Vaccination

Vaccination can prevent certain infections that can eventually lead to cancer.

HPV vaccination is a major example because persistent infection with high-risk HPV is responsible for nearly all cervical cancer cases.

Hepatitis B vaccination can also help prevent infections associated with liver cancer.

Expanding vaccination programmes could therefore contribute to long-term reductions in infection-related cancers.

Cancer Control Requires Multiple Strategies

There is no single solution to the global cancer challenge.

Countries need integrated strategies that combine:

• Prevention of major risk factors
• Vaccination against cancer-causing infections
• Evidence-based screening
• Early diagnosis
• Affordable treatment
• Palliative care
• Cancer registries and surveillance
• Research and innovation
• Public awareness

WHO’s 2026 report emphasises the need for people-centred cancer-control systems that address prevention, diagnosis, treatment, palliative care and survivorship.

Why Low- and Middle-Income Countries Need Special Attention

Cancer outcomes can differ substantially depending on where a person lives.

Countries with fewer healthcare resources may face greater challenges in screening, diagnosis, treatment and follow-up.

The IARC estimates that nearly half of cancer deaths among people diagnosed with cancer in 2022 could have been avoided through prevention, earlier detection and effective treatment, with the avoidable burden particularly large in countries with lower human-development levels.

Improving access to essential cancer services is therefore a major global health priority.

A Shift Toward Prevention

For many years, cancer discussions focused heavily on treatment.

Modern cancer policy increasingly recognises that prevention can produce enormous benefits before people become patients.

Reducing tobacco exposure, preventing cancer-causing infections, improving air quality and encouraging healthier environments can reduce the number of people who develop cancer in the first place.

This approach could also reduce pressure on hospitals and healthcare budgets.

The Role of Technology

Technology is rapidly changing cancer care.

Advanced imaging, molecular testing, genomic analysis and newer treatments are improving the ability of doctors to identify and treat some cancers.

Artificial intelligence may also assist with image interpretation and risk assessment in selected clinical settings.

However, technological progress will have the greatest public-health impact when these innovations become accessible to populations that currently have limited cancer services.

What Governments Can Do

WHO’s findings point toward several priorities for governments.

Strong tobacco-control measures can reduce one of the largest preventable cancer risks.

Vaccination programmes can prevent infection-related cancers.

Screening and early-diagnosis systems can identify disease sooner.

Investment in cancer treatment and essential medicines can improve survival.

Cleaner environments and healthier urban planning can also reduce exposure to certain risk factors.

The Road Ahead

The projected increase in cancer cases is a warning, but it is not a prediction that cannot be changed.

The evidence shows that many cancer risks are modifiable.

The challenge is turning scientific knowledge into effective public-health action.

Countries that invest in prevention, early diagnosis and accessible treatment can potentially reduce both deaths and the financial burden associated with cancer.

Conclusion

The latest WHO assessment presents a serious warning: global annual cancer cases could rise from around 20.6 million today to nearly 35 million by 2050 if stronger action is not taken.

At the same time, the situation offers a major opportunity.

WHO and IARC estimate that more than one-third of new cancer cases were linked to preventable causes in 2022.

Reducing tobacco use, preventing cancer-causing infections, improving air quality, encouraging healthier lifestyles and strengthening early detection could make a substantial difference.

The global fight against cancer is therefore not limited to developing better treatments.

The most effective long-term strategy is to prevent as many cancers as possible, detect disease earlier and ensure that effective treatment is available to everyone who needs it.